-
ImmunoGen Shares Soar Premarket on Takeover by AbbVie
30 Nov 2023 13:16 GMT
By Colin Kellaher
Shares of ImmunoGen took flight in premarket trading … a share in cash for ImmunoGen, some 95% above Wednesday…
-
ImmunoGen Shares Fall After Medical Chief's Exit, Spending Outlook
31 Jul 2023 17:20 GMT
By Dean Seal
Shares of Immunogen are trading lower after the … $17.84 in midday trading. Shares have more than tripled this …
-
ImmunoGen Shares Rally Premarket on Elahere Study Data >IMGN
05 Jun 2023 10:54 GMT
Shares of ImmunoGen jumped more than 15% in … three prior systemic treatment regimens. ImmunoGen in early May reported initial … of Elahere to full approval. Shares of ImmunoGen, which closed Friday at …
-
AbbVie's Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated Ovarian Cancer Patients
06 Jun 2024 17:41 GMT
… a $10 billion acquisition of Immunogen Inc.
Global Elahere net revenues … the recent acquisition of ImmunoGen.
Price Action: ABBV shares are up 1 …
-
ImmunoGen Shares Rise 96% on Positive Data From Elahere Trial
03 May 2023 12:37 GMT
By Chris Wack ImmunoGen Inc. shares were up 96% to $10. …
-
ImmunoGen Shares Jump 8.9% on FDA Accelerated Approval of Elahereump
14 Nov 2022 21:57 GMT
By Denny Jacob ImmunoGen Inc. shares rose 8.9% to $6. …
-
AbbVie Finalizes Deal to Acquire ImmunoGen With its Pipeline of Antibody Drug Conjugates
12 Feb 2024 20:05 GMT
… acquired in cash all outstanding shares of ImmunoGen for $31.26 per … dilutive impact from acquiring ImmunoGen.
Trading of ImmunoGen common stock on the … -,-Expanding-Solid-Tumor-Portfolio
3. ImmunoGen. ImmunoGen Announces FDA Accelerated Approval of …
-
ImmunoGen (NASDAQ:IMGN) Now Covered by StockNews.com
06 Feb 2024 06:56 GMT
StockNews.com started coverage on shares of ImmunoGen (NASDAQ:IMGN – Get Free … from $27.00) on shares of ImmunoGen in a research note on … .00 price target on shares of ImmunoGen in a research note … acquired a new stake in shares of ImmunoGen in the 2nd quarter …
-
Analysts Set ImmunoGen, Inc. (NASDAQ:IMGN) Target Price at $25.77
05 Feb 2024 07:02 GMT
… price objective on shares of ImmunoGen in a research … December 1st. Guggenheim cut shares of ImmunoGen from a “buy” rating … Aktiengesellschaft initiated coverage on shares of ImmunoGen in a research … initiated coverage on shares of ImmunoGen in a research …
-
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2024 21:39 GMT
… RSUs”) covering 68,940 shares of ImmunoGen’s common stock under … not previously employees of ImmunoGen (or following a bona … entering into employment with ImmunoGen, pursuant to Rule 5635 … covering the grants.
ABOUT IMMUNOGEN
ImmunoGen is developing the next …